Abstract:Heat shock proteins (HSP) have been revealed to interact with antigen-presenting cells and have potent adjuvant capability to induce antigen-specific CD8(+) CTL and Th1 responses. Our previous work shows how Hsp70-like protein 1 (Hsp70L1), as a new member of the Hsp70 subfamily, acts as potent Th1 adjuvant. Here, we report the efficient induction of tumor antigen-specific immune response by dendritic cells pulsed with recombinant fusion protein of Hsp70L1 and CEA(576-669) fragment of the carcinoembryonic antigen (CEA) containing CAP-1 (a HLA-A2-restricted CTL epitope). Fusion protein CEA(576-669)-Hsp70L1 can promote dendritic cell maturation and activate dendritic cells to produce cytokines, such as interleukin-12, interleukin-1 beta, and tumor necrosis factor-a, and chemokines, such as macrophage inflammatory protein-1 alpha, macrophage inflammatory protein-1 beta, and regulated on activation, normal T expressed and secreted, indicating the adjuvant ability of Hsp70L1 in the fusion protein. CEA-specific HLA-A2.1-restricted CD8(+) CTLs either from patients with CEA(+)/HLA-A2.1(+) colon carcinoma or from splenocytes of immunized HLA-A2.1/K-b transgenic mice can be generated more efficiently after stimulations or immunizations with dendritic cells pulsed by CEA(576-669)-Hsp70L1 than with dendritic cells pulsed by CEA(576-669) alone, resulting in secreting more Th1 cytokine IFN-gamma and killing target cells more potently in an antigen-specific and HLA-A2.1-restricted manner. Adoptive transfer of splenocytes from transgenic mice immunized with CEA(576-669)-Hsp70L1-pulsed dendritic cells can inhibit tumor growth and prolong survival in nude mice bearing CEA*/HLA-A2.1(+) human colon carcinoma more markedly. Therefore, Hsp70L1 has potent adjuvant effect in form of fusion protein, indicating that Hsp70L1 may be widely used as Th1 adjuvant to prepare antigenic fusion protein for the therapeutics of cancer or infectious diseases.

Induction of Anti-Tumor Immunity by Dendritic Cells Pulsed with an Endoplasmic Reticulum Retrieval Signal Modifies Heparanase Epitope in Mice.

Cytotoxic T Lymphocyte Epitopes from Human Heparanase Can Elicit a Potent Anti-Tumor Immune Response in Mice

H-2k(B)-Restricted Ctl Epitopes From Mouse Heparanase Elicit An Antitumor Immune Response In Vivo

Heparanase Epitope Peptide-Pulsed DCs Elicit Immune Responses Against Various Tumors in Vitro

Enhanced induction of dendritic cell maturation and HLA-A*0201-restricted CEA-specific CD8 + CTL response by exosomes derived from IL-18 gene-modified CEA-positive tumor cells

A Modified HLA-A*0201-restricted CTL Epitope from Human Oncoprotein (hpebp4) Induces More Efficient Antitumor Responses

Multiple antigenic peptides of human heparanase elicit a much more potent immune response against tumors.

Lewis X Oligosaccharides-Heparanase Complex Targeting to DCs Enhance Antitumor Response in Mice.

Myeloid Dendritic Cells Loaded with Dendritic Tandem Multiple Antigenic Telomerase Reverse Transcriptase (htert) Epitope Peptides: A Potentially Promising Tumor Vaccine

Synergistical Toll-Like Receptors Activated Dendritic Cells Induce Antitumor Effects Against Carcinoembryonic Antigen-Expressing Colon Cancer

In vitro and in vivo evaluation of DC-targeting PLGA nanoparticles encapsulating heparanase CD4+ and CD8+ T-cell epitopes for cancer immunotherapy

An Endoplasmic Reticulum Retrieval Signal Sequence Promotes MHC Class Ⅰ-presentation of Exogenous CTL Epitope Peptides

A Novel Approach for Cancer Immunotherapy: Tumor Cells with Anchored Superantigen SEA Generate Effective Antitumor Immunity

Targeted Delivery of Tumor Antigens to Activated Dendritic Cells Via CD11c Molecules Induces Potent Antitumor Immunity in Mice

HLA-A2–Restricted Cytotoxic T Lymphocyte Epitopes from Human Heparanase as Novel Targets for Broad-Spectrum Tumor Immunotherapy

DC Targeting DNA Vaccines Induce Protective and Therapeutic Antitumor Immunity in Mice.

Hsp70-Like Protein 1 Fusion Protein Enhances Induction Of Carcinoembryonic Antigen-Specific Cd8(+) Ctl Response By Dendritic Cell Vaccine

DNA vaccines targeting the encoded antigens to dendritic cells induce potent antitumor immunity in mice

A Novel Dendritic Cell Targeting HPV16 E7 Synthetic Vaccine in Combination with PD-L1 Blockade Elicits Therapeutic Antitumor Immunity in Mice.

Tumor Cell-associated Exosomes Robustly Elicit Anti-tumor Immune Responses through Modulating Dendritic Cell Vaccines in Lung Tumor

Active Antitumor Immunity Elicited by Vaccine Based on Recombinant Form of Epidermal Growth Factor Receptor